Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85


ALDH1 expression is enriched in breast cancers arising in young women but does not predict outcome.

Tan EY, Thike AA; Breast Surgical Team at Outram, Tan PH.

Br J Cancer. 2013 Jul 9;109(1):109-13. doi: 10.1038/bjc.2013.297. Epub 2013 Jun 20.


Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.

Ricardo S, Vieira AF, Gerhard R, Leitão D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F, Paredes J.

J Clin Pathol. 2011 Nov;64(11):937-46. doi: 10.1136/jcp.2011.090456. Epub 2011 Jun 16.


Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.

Miyoshi Y, Shien T, Ogiya A, Ishida N, Yamazaki K, Horii R, Horimoto Y, Masuda N, Yasojima H, Inao T, Osako T, Takahashi M, Tomioka N, Endo Y, Hosoda M, Doihara H, Miyoshi S, Yamashita H; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society.

Breast Cancer Res. 2016 Jul 2;18(1):73. doi: 10.1186/s13058-016-0731-3.


Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer.

Mieog JS, de Kruijf EM, Bastiaannet E, Kuppen PJ, Sajet A, de Craen AJ, Smit VT, van de Velde CJ, Liefers GJ.

BMC Cancer. 2012 Jan 26;12:42. doi: 10.1186/1471-2407-12-42.


Immunohistochemical detection of breast cancer stem cells in hormone receptor-positive breast cancer and their role in response to endocrine therapy and clinical outcome.

Hashimoto K, Shimizu C, Tsuda H, Saji S, Osaki A, Shigekawa T, Aogi K.

Oncology. 2012;82(3):168-74. doi: 10.1159/000336078. Epub 2012 Mar 15.


Clinicopathological analysis of breast ductal carcinoma in situ with ALDH1-positive cancer stem cells.

Tsukabe M, Shimazu K, Morimoto K, Naoi Y, Kagara N, Shimoda M, Shimomura A, Maruyama N, Kim SJ, Noguchi S.

Oncology. 2013;85(4):248-56. doi: 10.1159/000355476. Epub 2013 Oct 29.


Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression.

Morimoto K, Kim SJ, Tanei T, Shimazu K, Tanji Y, Taguchi T, Tamaki Y, Terada N, Noguchi S.

Cancer Sci. 2009 Jun;100(6):1062-8. doi: 10.1111/j.1349-7006.2009.01151.x. Epub 2009 Mar 9.


Co-expression of stem cell markers ALDH1 and CD44 in non-malignant and neoplastic lesions of the breast.

DA Cruz Paula A, Marques O, Rosa AM, DE Fátima Faria M, Rêma A, Lopes C.

Anticancer Res. 2014 Mar;34(3):1427-34.


Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.

De Brot M, Rocha RM, Soares FA, Gobbi H.

Pathology. 2012 Jun;44(4):303-12. doi: 10.1097/PAT.0b013e3283534bcb.


Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases.

Nogami T, Shien T, Tanaka T, Nishiyama K, Mizoo T, Iwamto T, Ikeda H, Taira N, Doihara H, Miyoshi S.

Breast Cancer. 2014 Jan;21(1):58-65. doi: 10.1007/s12282-012-0350-5. Epub 2012 Mar 10.


Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers.

Bane A, Viloria-Petit A, Pinnaduwage D, Mulligan AM, O'Malley FP, Andrulis IL.

Breast Cancer Res Treat. 2013 Jul;140(1):195-205. doi: 10.1007/s10549-013-2591-1. Epub 2013 Jun 28.


Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study.

Yoshioka T, Umekita Y, Ohi Y, Souda M, Sagara Y, Sagara Y, Sagara Y, Rai Y, Tanimoto A.

Histopathology. 2011 Mar;58(4):608-16. doi: 10.1111/j.1365-2559.2011.03781.x. Epub 2011 Mar 3.


Association of aldehyde dehydrogenase 1 expression and biologically aggressive features in breast cancer.

Kang EJ, Jung H, Woo OH, Park KH, Woo SU, Yang DS, Kim AR, Lee JB, Kim YH, Kim JS, Seo JH.

Neoplasma. 2014;61(3):352-62.


Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types.

de Beça FF, Caetano P, Gerhard R, Alvarenga CA, Gomes M, Paredes J, Schmitt F.

J Clin Pathol. 2013 Mar;66(3):187-91. doi: 10.1136/jclinpath-2012-201169. Epub 2012 Oct 30.


ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome.

Wang YC, Yo YT, Lee HY, Liao YP, Chao TK, Su PH, Lai HC.

Am J Pathol. 2012 Mar;180(3):1159-69. doi: 10.1016/j.ajpath.2011.11.015. Epub 2012 Jan 2. Erratum in: Am J Pathol. 2012 Jul;181(1):374.


The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.

Vogler T, Kriegl L, Horst D, Engel J, Sagebiel S, Schäffauer AJ, Kirchner T, Jung A.

Exp Mol Pathol. 2012 Feb;92(1):111-7. doi: 10.1016/j.yexmp.2011.10.010. Epub 2011 Nov 10.


The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis.

Zhou C, Sun B.

Oral Oncol. 2014 Dec;50(12):1144-8. doi: 10.1016/j.oraloncology.2014.08.018. Epub 2014 Sep 26. Review.


Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women.

Schwartz T, Stark A, Pang J, Awuah B, Kleer CG, Quayson S, Kingman S, Aitpillah F, Abantanga F, Jiagge E, Oppong JK, Osei-Bonsu E, Martin I, Yan X, Toy K, Adjei E, Wicha M, Newman LA.

Cancer. 2013 Feb 1;119(3):488-94. doi: 10.1002/cncr.27737. Epub 2012 Aug 28.


Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications.

Rahadiani N, Ikeda J, Mamat S, Matsuzaki S, Ueda Y, Umehara R, Tian T, Wang Y, Enomoto T, Kimura T, Aozasa K, Morii E.

Cancer Sci. 2011 Apr;102(4):903-8. doi: 10.1111/j.1349-7006.2011.01864.x. Epub 2011 Feb 9.


Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer.

Ohi Y, Umekita Y, Yoshioka T, Souda M, Rai Y, Sagara Y, Sagara Y, Sagara Y, Tanimoto A.

Histopathology. 2011 Oct;59(4):776-80. doi: 10.1111/j.1365-2559.2011.03884.x.


Supplemental Content

Support Center